Oragenics Inc (OGEN)
1.16
+0.03
(+2.65%)
USD |
NYAM |
Apr 19, 16:00
1.16
0.00 (0.00%)
After-Hours: 18:21
Oragenics Cash from Operations (Quarterly): -1.102M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -1.102M |
| September 30, 2023 | -1.503M |
| June 30, 2023 | -2.577M |
| March 31, 2023 | -2.109M |
| December 31, 2022 | -2.433M |
| September 30, 2022 | -3.776M |
| June 30, 2022 | -3.383M |
| March 31, 2022 | -5.637M |
| December 31, 2021 | -1.884M |
| September 30, 2021 | -5.18M |
| June 30, 2021 | -2.078M |
| March 31, 2021 | -4.327M |
| December 31, 2020 | -3.632M |
| September 30, 2020 | -4.666M |
| June 30, 2020 | -4.833M |
| March 31, 2020 | -3.823M |
| Date | Value |
|---|---|
| December 31, 2019 | -3.936M |
| September 30, 2019 | -3.378M |
| June 30, 2019 | -3.488M |
| March 31, 2019 | -2.211M |
| December 31, 2018 | -2.978M |
| September 30, 2018 | -2.454M |
| June 30, 2018 | -2.281M |
| March 31, 2018 | -1.367M |
| December 31, 2017 | -1.359M |
| September 30, 2017 | -1.340M |
| June 30, 2017 | -1.765M |
| March 31, 2017 | -1.900M |
| December 31, 2016 | -1.964M |
| September 30, 2016 | -1.673M |
| June 30, 2016 | -1.756M |
| March 31, 2016 | -1.682M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-5.637M
Minimum
Mar 2022
-1.102M
Maximum
Dec 2023
-3.355M
Average
-3.488M
Median
Jun 2019
Cash from Operations (Quarterly) Benchmarks
| Palatin Technologies Inc | -10.48M |
| Inogen Inc | -3.148M |
| Ampio Pharmaceuticals Inc | -2.309M |
| Actinium Pharmaceuticals Inc | -7.49M |
| MAIA Biotechnology Inc | -3.992M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -1.00M |
| Cash from Financing (Quarterly) | -0.1806M |
| Free Cash Flow | -7.291M |
| Free Cash Flow Per Share (Quarterly) | -0.4257 |
| Free Cash Flow Yield | -279.5% |